• OPEN AN ACCOUNT
Indian Indices
Sensex
80,999.40 -28.62
( -0.04%)
Global Indices
Nasdaq
51,462.04 -82.02
(-0.16%)
Dow Jones
7,424.83 50.10
(0.68%)
Hang Seng
57,293.47 -3,784.43
(-6.20%)
Nikkei 225
10,662.59 -120.07
(-1.11%)
Forex
USD-INR
94.41 -0.18
(-0.19%)
EUR-INR
106.07 -0.23
(-0.22%)
GBP-INR
127.18 -0.23
(-0.18%)
JPY-INR
0.60 0.00
(-0.04%)

EQUITY - MARKET SCREENER

Aurobindo Pharma Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524804
INE406A01037
406.2420157
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
AUROPHARMA
37.81
103913.25
EPS(TTM)
Face Value()
Div & Yield %
47.76
1
0.22
 

As on: Nov 08, 2026 12:00 AM

Last Price() Net Change (%) Volume (Nos) P / E
1,806.00 9.00 3696 37.81
Stock Price Details
Open Price() 1,813.45
Best Buy () 0
Best Sell () 0
Buy Quantity (Nos) 0
Sell Quantity (Nos) 0
Today's High () 1,815.00
Today's Low () 1,797.55
52-Week High () 1815
152-Week Low () 1106.25
CHART
  • |
  • |
  • |
  • |
Market Statistics
Div & Yield % 0.22
Eps 47.76
Book Value 406.2420157
Market Cap (.Cr) 103,913.25
Face Value 1
Market Lot 1
AGM Date Aug
Book Closure Date Aug
ISIN No. INE406A01037


News
Aurobindo Pharma consolidated net profit rises 32.72% in the September 2026 quarter
Board of Aurobindo Pharma recommends interim dividend
Aurobindo Pharma Ltd up for five straight sessions
Aurobindo Pharma Ltd up for third consecutive session
Aurobindo Pharma to announce Quarterly Result
Aurobindo Pharma receives USFDA approval for Beclomethasone Dipropionate HFA Inhalation Aerosol
Aurobindo Pharma receives US FDA nod for metered Beclomethasone Dipropionate aerosol
Aurobindo Pharma Ltd soars 1.19%
Aurobindo Pharma Ltd spurts 3.36%, gains for fifth straight session
Aurobindo Pharma's Unit-VI completes USFDA inspection
More
Corporate Details
Incoporation Year   : 1986
Chairman : M R Kumar
Bussiness Group : Indian Private
Registered Office
Aurobindo Pharma Ltd
Plot No 2 Maitrivihar,
Behind Maithri Vanam Ameerpet,
Hyderabad,
Telangana-500038
Cement House,
121 Maharshi Karve Road,
Mumbai,
Maharashtra-400020
Phone:91-40-23736370
Fax:91-40-23747340
Fax:91-22-66317458
E-Mail : cs@aurobindo.com; investorgrievances@aurobindo.com
URL : http://www.aurobindo.com


Exchange Information
Bombay Stock Exchange National Stock Exchange Other Listed Exchanges
  • BSE 500
  • BSE 200
  • BSE HC
  • BSE DOLLEX
  • BSE Midcap
  • CNX 500
  • Nifty Midcap50
  • CNX Midcap
  • CNX Pharma
  • CNX 200
  • BSE
  • Kolkata
  • Chennai
  • Ahmedabad
  • Delhi
  • Kochi